ISSN 2415-1297 (Online)   ISSN 2415-1300 (Print)
 
             
 
Volume : 25 Issue : 3 Year : 2017
 
Bilateral Simultaneous Femoral Fragility Fractures after Long-term Alendronate Therapy [Med J Islamic World Acad Sci]
Med J Islamic World Acad Sci. 2016; 24(1): 20-23 | DOI: 10.5505/ias.2016.37232  

Bilateral Simultaneous Femoral Fragility Fractures after Long-term Alendronate Therapy

Yalçın Turhan, Yavuz Geçer, Zekeriya O. Karaduman, Cemal Güler, Mücahid O. Yücel
Department of Orthopaedics and Traumatology, School of Medicine, Düzce University, Düzce, Turkey.

Alendronate is the most popular bisphosphonate used to prevent osteoporotic fragility fractures in postmenopausal women. However, an increasing number of reports show a possible association between long-term treatment with biphosphanates and the occurrence of characteristic femoral fragility fractures. This study reported a case of a bilateral femoral insufficiency fracture in a woman receiving long-term alendronate therapy. The woman suffered from bilateral femoral pain while having physical therapy in the hospital and sustained a right displaced and left nondisplaced femoral shaft fracture. The characteristics and natural course of this bilateral fracture was analyzed and the importance of being aware of the possible correlation between long-term alendronate therapy and insufficiency femoral fractures was emphasized.

Keywords: Alendronate, femur fracture, osteoporosis


Yalçın Turhan, Yavuz Geçer, Zekeriya O. Karaduman, Cemal Güler, Mücahid O. Yücel. Bilateral Simultaneous Femoral Fragility Fractures after Long-term Alendronate Therapy. Med J Islamic World Acad Sci. 2016; 24(1): 20-23

Corresponding Author: Yalçın Turhan, Türkiye


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar




 











 
Copyright © 2017 medicaljournal-ias.org. All Rights Reserved.